Monika Denk

A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity

Jonas S. Heitmann, Tatjana Bilich, Claudia Tandler et al. · Nature · 2021 · 275 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A H3K27M-targeted vaccine in adults with diffuse midline glioma

Isabel Poschke, Katharina A.M. Lindner, Lukas Bunse et al. · Nature Medicine · 2023 · 78 citations · Full text

Medicine, Immunology, Oncology +17

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

Jens Bauer, Natalie Köhler, Yacine Maringer et al. · Nature Communications · 2022 · 76 citations · Full text

Life Sciences, Immunology, Oncology +17

AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomas

Lukas Bunse, Anne-Kathleen Rupp, Isabel Poschke et al. · Neurological Research and Practice · 2022 · 40 citations · Full text

Life Sciences, Immunology, Oncology +17

Guidance Document: Validation of a High-Performance Liquid Chromatography-Tandem Mass Spectrometry Immunopeptidomics Assay for the Identification of HLA Class I Ligands Suitable for Pharmaceutical Therapies

Michael Ghosh, Marion Gauger, Ana Marcu et al. · Molecular & Cellular Proteomics · 2020 · 38 citations · Full text

Life Sciences, Biotechnology, Immunology +17